Vicarious Surgical (RBOTW) Change in Accured Expenses (2020 - 2025)
Vicarious Surgical (RBOTW) reported Change in Accured Expenses of -$2.2 million for Q3 2025, down 778.06% year-over-year from $319000.0 in Q3 2024, and up 13.55% quarter-over-quarter from -$2.5 million in Q2 2025.
Vicarious Surgical (RBOTW) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q3 2025.
- Change in Accured Expenses for Q3 2025 came in at -$2.2 million, down 778.06% year-over-year; the trailing twelve-month figure through Sep 2025 was -$4.1 million (down 1530.16% YoY), and the FY2024 annual result was $309000.0, up 137.09% from the prior year.
- Change in Accured Expenses advanced to -$2.2 million in Q3 2025 per RBOTW's latest filing, from -$2.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.8 million in Q4 2021 and troughed at -$2.5 million in Q2 2025.
- A 5-year average of $27000.0 and a median of $287000.0 in 2025 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 10227.55% in 2021 and fell as far as 5779.1% in 2021.
- A 5-year view of Change in Accured Expenses shows it stood at $2.8 million in 2021, then tumbled by 84.42% to $443000.0 in 2022, then sank by 165.69% to -$291000.0 in 2023, then surged by 192.78% to $270000.0 in 2024, then sank by 901.11% to -$2.2 million in 2025.
- Business Quant data shows RBOTW's Change in Accured Expenses at -$2.2 million in Q3 2025, -$2.5 million in Q2 2025, and $287000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.16 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 287,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -291,000.00 |
| Dec 31, 2023 | -291,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |